Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - risedronate sodium hemipentahydrate -

Israel - English - Ministry of Health

taro pharmaceutical industries ltd - calcium carbonate - chewable tablets - calcium carbonate 600 mg - calcium carbonate - calcium carbonate - antacid, calcium deficiency.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - risedronate sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - risedronate sodium, quantity: 150 mg - tablet, film coated - excipient ingredients: macrogol 8000; microcrystalline cellulose; hyprolose; colloidal anhydrous silica; hypromellose; crospovidone; indigo carmine; titanium dioxide; magnesium stearate; macrogol 400 - treatment of osteoporosis. treatment of glucocorticoid-induced osteoporosis. preservation of bone mineral density in patients on long-term corticosteroid therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

bafna pharmaceuticals pty ltd - risedronate sodium hemipentahydrate, quantity: 172.1 mg (equivalent: risedronate sodium, qty 150 mg) - tablet, film coated - excipient ingredients: crospovidone; colloidal anhydrous silica; microcrystalline cellulose; mannitol; magnesium stearate; titanium dioxide; hypromellose; macrogol 8000; sunset yellow fcf aluminium lake; polydextrose; macrogol 400; indigo carmine aluminium lake - ? treatment of osteoporosis.,? treatment of glucocorticoid-induced osteoporosis.,? preservation of bone mineral density in patients on long term corticosteroid therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - risedronate sodium hemipentahydrate, quantity: 86.7 mg - tablet, film coated - excipient ingredients: hypromellose; titanium dioxide; macrogol 8000; iron oxide red; colloidal anhydrous silica; hyprolose; magnesium stearate; crospovidone; lactose - the treatment of osteoporosis,the treatment of glucocorticoid-induced osteoporosis,the preservation of bone-mineral density in patients on long term corticosteroid therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - risedronate sodium hemipentahydrate, quantity: 86.7 mg - tablet, film coated - excipient ingredients: hyprolose; iron oxide red; colloidal anhydrous silica; magnesium stearate; hypromellose; macrogol 8000; crospovidone; titanium dioxide; lactose - the treatment of osteoporosis,the treatment of glucocorticoid-induced osteoporosis,the preservation of bone-mineral density in patients on long term corticosteroid therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - risedronate sodium hemipentahydrate, quantity: 40.5 mg (equivalent: risedronate sodium, qty 35 mg) - tablet, film coated - excipient ingredients: hypromellose; titanium dioxide; macrogol 8000; lactose; magnesium stearate; iron oxide red; crospovidone; hyprolose; colloidal anhydrous silica; iron oxide yellow - - treatment of osteoporosis. - treatment of glucocorticoid-induced osteoporosis. - preservation of bone mineral density in patients on long term corticosteroid therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - alendronate sodium,calcium carbonate,colecalciferol -

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - alendronate sodium,calcium carbonate,colecalciferol -